Literature DB >> 3154589

The effect of blepharoptosis on the field of vision.

K V Cahill1, J A Burns, P A Weber.   

Abstract

Upper eyelid position, pupillary diameter, and visual field impairment were measured in 26 eyes with adult-onset blepharoptosis. The magnitude of superior visual field impairment was inversely proportional to the distance between the upper lid margin and the pupillary aperture. The distance between the upper lid and the central corneal reflex was the most useful measurement for predicting visual field impairment. Superior visual field impairment was present when the distance between the upper lid and the central corneal reflex was less than 2.5 mm. Visual field impairment inferiorly, temporally, and nasally occurred when the central corneal reflex was obscured and less than 1.5 mm of the vertical diameter of the pupil was visible. Observation of the relationship between the upper eyelid and the pupillary aperture provides useful information for the performance of accurate diagnostic perimetry, as well as for the management of blepharoptosis.

Entities:  

Mesh:

Year:  1987        PMID: 3154589     DOI: 10.1097/00002341-198703030-00001

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

1.  Modified visual field test for ptosis surgery (Leicester Peripheral Field Test).

Authors:  S F Ho; A Morawski; R Sampath; J Burns
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

2.  Tangent screen perimetry in the evaluation of visual field defects associated with ptosis and dermatochalasis.

Authors:  Molly L Fuller; César A Briceño; Christine C Nelson; Elizabeth A Bradley
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

3.  Eyelid Crease Height Affects the Evaluation of Age-related Changes in the Eyelids.

Authors:  Shinsuke Akita; Satoshi Maki; Yuki Shiko; Yohei Kawasaki; Yoshihisa Yamaji; Hideki Tokumoto; Kentaro Kosaka; Hideyuki Ogata; Yoshitaka Kubota; Nobuyuki Mitsukawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-11-04

4.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

5.  Impact of Single Eyelid on Superior Visual Field.

Authors:  Takeshi Kitazawa; Shunsuke Yuzuriha
Journal:  Ann Plast Surg       Date:  2022-04-01       Impact factor: 1.539

6.  Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

Authors:  Jason Bacharach; David L Wirta; Robert Smyth-Medina; Michael S Korenfeld; Shane R Kannarr; Shane Foster; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.